CD19 regulates B lymphocyte responses to transmembrane signals

Seminars in Immunology

Volumn 10, Issue 4, 1998, Pages 267-277

  Fujimoto, Manabu ^b   Poe, Jonathan C ^b   Inaoki, Makoto ^b   Tedder, Thomas F ^a  

^a DUKE UNIVERSITY MEDICAL CENTER   (United States)

^b NONE

Author keywords

B lymphocyte; CD19; Humoral immunity; Immunoglobulin; Src family protein tyrosine kinase; Vav

Indexed keywords

CD19 ANTIGEN; LYMPHOCYTE ANTIGEN RECEPTOR;

B LYMPHOCYTE; MOUSE; NONHUMAN; PROTEIN PHOSPHORYLATION; REVIEW; SIGNAL TRANSDUCTION;

EID: 0032147183     PISSN: 10445323     EISSN: None     Source Type: Journal    
DOI: 10.1006/smim.1998.9999     Document Type: Article

References (82)

1. 1. Tedder TF, Inaoki M, Sato S (1997) The CD19/21 complex regulates signal transduction thresholds governing humoral immunity and autoimmunity. Immunity 6:107-118
2. 2. Tedder TF, Zhou L-J, Engel P (1994) The CD19/CD21 signal transduction complex of B lymphocytes. Immunol Today 15:437-442
3. 3. Fearon DT, Carter RH (1995) The CD19/CR2/TAPA-1 complex of B lymphocytes: linking natural to acquired immunity. Annu Rev Immunol 13:127-149
4. 4. Nadler LM, Anderson KC, Marti G, Bates M, Park E, Daley JF, Schlossman SF (1983) B4, a human B lymphocyte-associated antigen expressed on normal, mitogen activated, and malignant B lymphocytes. J Immunol 131:244-250
5. 5. Sato S, Ono N, Steeber DA, Pisetsky DS, Tedder TF (1996) CD19 regulates B lymphocyte signaling thresholds critical for the development of B-1 lineage cells and autoimmunity. J Immunol 156:4371-4378
6. 6. Krop I, Shaffer AL, Fearon DT, Schlissel MS (1996) The signaling activity of murine CD19 is regulated during B cell development. J Immunol 157:48-56
7. 7. Tedder TF, Isaacs CM (1989) Isolation of cDNAs encoding the CD 19 antigen of human and mouse B lymphocytes: A new member of the immunoglobulin superfamily. J Immunol 143:712-717
8. 8. Zhou L-J, Ord DC, Hughes AL, Tedder TF (1991) Structure and domain organization of the CD19 antigen of human, mouse and guinea pig B lymphocytes. Conservation of the extensive cytoplasmic domain. J Immunol 147:1424-1432
9. 9. Matsumoto AK, Kopicky-Burd J, Carter RH, Tuveson DA, Tedder TF, Fearon DT (1991) Intersection of the complement and immune systems: A signal transduction complex of the B lymphocyte containing complement receptor type 2 and CD19. J Exp Med 173:55-64
10. 10. Bradbury LE, Kansas GS, Levy S, Evans RL, Tedder TF (1992) The CD19/CD21 signal transducing complex of human B lymphocytes includes the target of antiproliferative antibody-1 and Leu-13 molecules. J Immunol 149:2841-2850
11. 11. Bradbury LE, Goldmacher VS, Tedder TF (1993) The CD19 signal transduction complex of B lymphocytes: deletion of the CD 19 cytoplasmic domain alters signal transduction but not complex formation with TAPA-1 and Leu-13. J Immunol 151:2915-2927
12. 12. Tuveson DA, Ahearn JM, Matsumoto AK, Fearon DT (1991) Molecular interactions of complement receptors on B lymphocytes: a CR1/CR2 complex distinct from the CR2/CD19 complex. J Exp Med 173:1083-1089
13. 13. Maecker HT, Levy S (1997) Normal lymphocyte development but delayed humoral immune response in CD81-null mice. J Exp Med 185:1505-1510
14. 14. Pezzutto A, Dörken B, Moldenhauer G, Clark EA (1987) Amplification of human B cell activation by a monoclonal antibody to the B cell-specific antigen CD22, Bp130/140. J Immunol 138:98-103
15. 15. Barrett TB, Shu GL, Draves KE, Pezzutto A, Clark EA (1990) Signaling through CD19, Fc receptors or transforming growth factor-β: each inhibits the activation of resting human B cells differently. Eur J Immunol 20:1053-1059
16. 16. Callard RE, Rigley KP, Smith SH, Thurstan S, Shields JG (1992) CD19 regulation of human B cell responses. B cell proliferation and antibody secretion are inhibited or enhanced by ligation of the CD19 surface glycoprotein depending on the stimulating signal used. J Immunol 148:2983-2987
17. 17. De Rie MA, Schumacher TNM, van Schijndel GMW, van Lier RAW, Miedema F (1989) Regulatory role of CD19 molecules in B-cell activation and differentiation. Cell Immunol 118:368-381
18. 18. Carter RH, Fearon DT (1992) GD19: lowering the threshold for antigen receptor stimulation of B lymphocytes. Science 256:105-107
19. 19. Uckun FM, Burkhardt AL, Jarvis L, Jun X, Stealey B, Dibirdik I, Myers DE, Tuel-Ahlgren L, Bolen JB (1993) Signal transduction through the CD19 receptor during discrete developmental stages of human B-cell ontogeny. J Biol Chem 268:21772-21184
20. 20. Pezzutto A, Dorken B, Rabinovitch PS, Ledbetter JA, Moldenhauer G, Clark EA (1987) CD19 monoclonal antibody HD37 inhibits anti-immunoglobulin-induced B cell activation and proliferation. J Immunol 138:2793-2799
21. 21. Chalupny NJ, Kanner SB, Schieven GL, Wee S, Gilliland LK, Aruffo A, Ledbetter JA (1993) Tyrosine phosphorylation of CD19 in pre-B and mature B cells. EMBO J 12:2691-2696
22. 22. Billips LG, Nunez CA, Bertrand III FE, Stankovic AK, Gartland GL, Burrows PD, Cooper MD (1995) Immunoglobulin recombinase gene activity is modulated reciprocally by interleukin-7 and CD 19 in B cell progenitors. J Exp Med 182:973-982
23. 23. Sato S, Miller AS, Howard MC, Tedder TF (1997) Regulation of B lymphocyte development and activation by the CD19/CD21/CD81/Leu 13 complex requires the cytoplasmic domain of CD19. J Immunol 159:3278-3287
24. 24. Engel P, Zhou L-T, Ord DC, Sato S, Koller B, Tedder TF (1995) Abnormal B lymphocyte development, activation and differentiation in mice that lack or overexpress the GD19 signal transduction molecule. Immunity 3:39-50
25. 25. Rickert RC, Rajewsky K, Roes J (1995) Impairment of T-cell-dependent B-cell responses and B-1 cell development in CD19-deficient mice. Nature 376:352-355
26. 26. Sato S, Steeber DA, Jansen PJ, Tedder TF (1997) CD19 expression levels regulate B lymphocyte development: human CD19 restores normal function in mice lacking endogenous CD19. J Immunol 158:4662-4669
27. 27. Sato S, Steeber DA, Tedder TF (1995) The CD19 signal transduction molecule is a response regulator of B-lymphocyte differentiation. Proc Natl Acad Sci USA 92:11558-11562
28. 28. Krop I, de Fougerolles AR, Hardy RA, Allison M, Schlissel MS, Fearon DT (1996) Self-renewal of B-1 lymphocytes is dependent on CD19. Eur J Immunol 26:238-242
29. 29. Zhou L-J, Smith HM, Waldschmidt TJ, Schwarting R, Daley J, Tedder TF (1994) Tissue-specific expression of the human CD19 gene in transgenic mice inhibits antigen-independent B lymphocyte development. Mol Cell Biol 14:3884-3894
30. 30. Goodnow CC (1992) Transgenic mice and analysis of B-cell tolerance. Annu Rev Immunol 10:489-518
31. 31. Goodnow CC, Crosbie J, Adelstein S, Lavoie TB, Smith-Gill SJ, Brink RA, Pritchard-Briscoe H, Wotherspoon JS, Loblay RH, Raphael K, Trent RJ, Basten A (1988) Altered immunoglobulin expression and functional silencing of self-reactive B lymphocytes in transgenic mice. Nature 334:676-682
32. 32. Inaoki M, Sato S, Weintraub BC, Goodnow CC, Tedder TF (1997) CD19-regulated signaling thresholds control peripheral tolerance and autoantibody production in B lymphocytes. J Exp Med 186:1923-1931
33. 33. Croix DA, Ahearn JM, Rosengard AM, Han S, Kelsoe G, Ma M, Carroll MC (1996) Antibody response to a T-dependent antigen requires B cell expression of complement receptors. J Exp Med 183:1857-1864
34. 34. Fischer MB, Ma M, Goerg S, Zhou X, Xia T, Finco O, Han S, Kelsoe G, Howard RG, Rothstein TL, Kremmer E, Rosen F, Carroll MC (1996) Regulation of the B cell response to T-dependent antigens by classical pathway complement. J Immunol 157:549-556
35. 35. Ahearn JM, Fischer MB, Croix D, Goerg S, Ma M, Xia J, Zhou X, Howard RG, Rothstein TL, Carroll MC (1996) Disruption of the Cr2 locus results in a reduction in B-1a cells and in an impaired B cell response to T-dependent antigen. Immunity 4:251-262
36. 36. Molina H, Holers VM, Li B, Fang Y-F, Mariathasan S, Goellner J, Strauss-Schoenberger J, Karr RW, Chaplin DD (1996) Markedly impaired humoral immune response in mice deficient in complement receptors 1 and 2. Proc Natl Acad Sci USA 93:3357-3361
37. 37. Kitanaka A, Ito C, Coustan-Smith E, Campana D (1997) CD38 ligation in human B cell progenitors triggers tyrosine phosphorylation of CD19 and association of CD19 with Lyn and phosphatidylinositol 3-kinase. J Immunol 159:184-192
38. 2+ mobilization is integrated by CD19 dephosphorylation. Immunity 7:49-58
39. 39. van Noesel CJ, Lankester AC, van Schijndel GM, van Lier RA (1993) The CR2/CD19 complex on human B cells contains the src-family kinase Lyn. Int Immunol 5:699-705
40. 40. Chalupny NJ, Aruffo A, Esselstyn JM, Chan PY, Bajorath J, Blake J, Gilliland LK, LedbetterJA, Tepper MA (1995) Specific binding of Fyn and phosphatidylinositol 3-kinase to the B cell surface glycoprotein CD19 through their src homology 2 domains. Eur J Immunol 25:2978-2984
41. 41. Carter RH, Doody GM, Bolen JB, Fearon DT (1997) Membrane IgM-induced tyrosine phosphorylation of CD19 requires a CD19 domain that mediates association with components of the B cell antigen receptor complex. J Immunol 158:3062-3069
42. 42. Tuveson DA, Carter RH, Soltoff SP, Fearon DT (1993) CD19 of B cells as a surrogate kinase insert region to bind phosphatidylinositol 3-kinase. Science 260:986-989
43. 43. Weng WK, Jarvis L, LeBien TW (1994) Signaling through CD19 activates vav/mitogen-activated protein kinase pathway and induces formation of a CD19/vav/phosphatidylinositol 3-kinase complex in human B cell precursors. J Biol Chem 269:32514-32521
44. 44. Li X, Sandoval D, Freeberg L, Carter RH (1997) Role of CD19 tyrosine 391 in synergistic activation of B lymphocytes by colligation of CD19 and membrane Ig. J Immunol 158:5649-5657
45. 2+ mobilization. J Exp Med 186:1897-1910
46. 46. Beckwith M, Jorgensen G, Longo DL (1996) The protein product of the proto-oncogene c-cbl forms a complex with phosphatidylinositol 3-kinase p85 and CD 19 in anti-IgM-stimulated human B-lymphoma cells. Blood 88:3502-3507
47. 47. Lankester AC, van Schijndel GMW, Rood PML, Verhoeven AJ, van Lier RAW (1994) B cell antigen receptor cross-linking induced tyrosine phosphorylation and membrane translocation of a multimeric She complex that is augmented by CD19 co-ligation. Eur J Immunol 24:2818-2825
48. 48. Burkhardt AL, Brunswick M, Bolen JB, Mond JJ (1991) Antiimmunoglobulin stimulation of B lymphocytes activates srcrelated protein-tyrosine kinases. Proc Natl Acad Sci USA 88:7410-7414
49. 49. Hutchcroft JE, Harrison ML, Geahlen RL (1992) Association of the 72 kDa protein-tyrosine kinase PTK72 with the B cell antigen receptor. J Biol Chem 267:8613-8619
50. 50. Tooze RM, Doody GM, Fearon DT (1997) Counterregulation by the coreceptors CD19 and CD22 of MAP kinase activation by membrane immunoglobulin. Immunity 7:59-67
51. 51. Carter RH, Tuveson DA, Park DJ, Rhee SG, Fearon DT (1991) The CD19 complex of B lymphocytes. Activation of phospholipase C by a protein tyrosine kinase-dependent pathway that can be enhanced by the membrane IgM complex. J Immunol 147:3663-3671
52. 52. Weng W-K, Shah N, O'Brien D, Van Ness B, LeBien TW (1997) Differential induction of DNA-binding activities following CD19 cross-linking in human B lineage cells. J Immunol 159:5502-5508
53. 53. Wienands J, Larbolette O, Reth M (1996) Evidence for a preformed transducer complex organized by the B cell antigen receptor. Proc Natl Acad Sci USA 93:7865-7870
54. 54. van Oers NSC, Killeen N, Weiss A (1994) ZAP-70 is constitutively associated with tyrosine-phosphorylated TCR ζ in murine thymocytes and lymph node T cells. Immunity 1:675-685
55. 55. Bell SE, Goodnow CC (1994) A selective defect in IgM antigen receptor synthesis and transport causes loss of cell surface IgM expression on tolerant B lymphocytes. EMBO J 13:816-826
56. 56. Fujimoto M, Sato S, Jansen PJ, Poe JC, Tedder TF (1998) CD19 expression regulates tyrosine phosphorylation of Srcfamily protein tyrosine kinases following B cell antigen receptor ligation (submitted for publication)
57. 57. Pani G, Siminovitch KA, Paige CJ (1997) The motheaten mutation rescues B cell signaling and development in CD45-deficient mice. J Exp Med 186:581-588
58. 58. El-Hillal O, Kurosaki T, Yamamura H, Kinet J-P, Scharenberg AM (1997) Syk kinase activation by a src kinase-initiated activation loop phosphorylation chain reaction. Proc Natl Acad Sci USA 94:1919-1924
59. 2+ mobilization through distinct pathways. EMBO J 13:1341-1349
60. 60. Collins TL, Deckert M, Altman A (1997) Views on Vav. Immunol Today 18:221-225
61. 61. Deckert M, Tertare-Deckert S, Couture C, Mustelin T, Altman A (1996) Functional and physical interactions of Syk family kinases with the Vav proto-oncogene product. Immunity 5:591-604
62. 62. Nagai K, Takata M, Yamamura H, Kurosaki T (1995) Tyrosine phosphorylation of She is mediated through Lyn and Syk in B cell receptor signaling. J Biol Chem 270:6824-6829
63. cbl is a major substrate of tyrosine phosphorylation upon B cell antigen receptor stimulation and interacts in vivo with Fyn and Syk tyrosine kinases, Grb2 and She adaptors, and the p85 subunit of phosphatidylinositol 3 kinase. J Biol Chem 271:3187-3194
64. lyn, in the B cell antigen receptor-mediated signaling. J Exp Med 183:675-680
65. 65. Sato S, Jansen PJ, Tedder TF (1997) CD19 and CD22 reciprocally regulate Vav tyrosine phosphorylation during B lymphocyte signaling. Proc Natl Acad Sci USA 94:13158-13162
66. 66. Gupta S, Weiss A, Kumar G, Wang S, Nel A (1994) The T-cell antigen receptor utilizes Lck, Raf-1, and MEK-1 for activating mitogen-activated protein kinase. J Biol Chem 269:17349-17357
67. 67. Nishizumi H, Taniuchi I, Yamanashi Y, Katamura D, Ilic D, Mori S, Watanabe T, Yamamoto T (1995) Impaired proliferation of peripheral B cells and indication of autoimmune disease in lyn-deficient mice. Immunity 3:549-560
68. 68. Tarakhovsky A, Turner M, Shaal S, Mee PJ, Buddy LP, Rajewsky K, Tybulewicz V (1995) Defective antigen receptor-mediated proliferation of B and T cells in the absence of Vav. Nature 374:467-470
69. 69. Zhang R, Alt FW, Davidson L, Orkin SH, Swat W (1995) Defective signalling through the T- and B-cell antigen receptors in lymphoid cells lacking the vav proto-oncogene. Nature 374:470-473
70. 70. Tedder TF, Tuscano J, Sato S, Kehrl JH (1997) CD22, a B lymphocyte-specific adhesion molecule that regulates antigen receptor signaling. Annu Rev Immunol 15:481-504
71. 71. Schulte RJ, Campbell M-A, Fischer WH, Sefton BM (1992) Tyrosine phosphorylation of CD22 during B cell activation. Science 258:1001-1004
72. 72. Chan VWF, Meng F, Soriano P, Defranco AL, Lowell CA (1997) Characterization of the B lymphocyte populations in Lyn-deficient mice and the role of Lyn in signal initiation and down-regulation. Immunity 7:69-81
73. 73. Sato S, Miller AS, Inaoki M, Bock CB, Jansen PJ, Tang MLK, Tedder TF (1996) CD22 is both a positive and negative regulator of B lymphocyte antigen receptor signal transduction: altered signaling in CD22-deficient mice. Immunity 5:551-562
74. 74. O'Keefe TL, Williams GT, Davies SL, Neuberger MS (1996) Hyperresponsive B cells in CD22-deficient mice. Science 274:798-801
75. 75. Cyster JG, Goodnow CC (1997) Tuning antigen receptor signaling by CD22: Integrating cues from antigens and the microenvironment. Immunity 6:509-517
76. 76. Hibbs ML, Tarlinton DM, Armes T, Grail D, Hodgson G, Maglitto R, Stacker SA, Dunn AR (1995) Multiple defects in the immune system of Lyn-deficient mice, culminating in autoimmune disease. Cell 83:301-311
77. 77. DeFranco AL (1997) The complexity of signaling pathways activated by the BCR. Curr Opin Immunol 9:296-308
78. 78. Unkeless JC, Jin J (1997) Inhibitory receptors, ITIM sequences and phosphatases. Curr Opin Immunol 9:938-943
79. 79. Tridandapani S, Kelley T, Cooney D, Pradhan M, Coggeshall KM (1997) Negative signaling in B cells: SHIP Grbs Shc. Immunol Today 18:424-427
80. 80. Takata M, Kurosaki T (1996) A role for Bruton's tyrosine kinase in B cell antigen receptor-mediated activation of phospholipase C-γ2. J Exp Med 184:31-40
81. 81. Scharenberg AM, Kinet J-P (1996) The emerging field of receptor-mediated inhibitory signaling: SHP or SHIP? Cell 87:961-964
82. 82. Choquet D, Partiseti M, Amigorena S, Bonnerot C, H. FW, Korn H (1993) Cross-linking of IgG receptors inhibits membrane immunoglobulin-stimulated calcium influx in B lymphocytes. J Cell Biol 121:355-363